This live web event has ended. Thank you for attending.
Speakers will discuss the gaps in the lung cancer diagnosis
and care continuum and the transformative role of novel genomic tests, such as
a non-invasive nasal swab for early lung cancer detection and a comprehensive
genomic profiling test for more informed treatment decision making. This
webinar will also provide an overview of the Percepta Genomic Sequencing
Classifier to stratify the risk of lung cancer when bronchoscopy is
inconclusive and how to integrate this test into clinical practice.
This program is sponsored by Veracyte.
By registering for this webinar, you agree your information will be shared with the sponsor.
No CME or MOC credits are available for this program.
Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.